Inhibition of Atherosclerosis by Angiotensin II Type 1 Receptor Antagonists
Low-Density Lipoprotein Cholesterol: How Low Can We Go?
Antiplatelet and Anticoagulant Therapy for Atherothrombotic Disease: The Role of Current and Emerging Agents
Contemporary Drug Treatment of Infective Endocarditis
Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation
Adherence and Persistence with Prasugrel Following Acute Coronary Syndrome with Percutaneous Coronary Intervention
Clinical Outcomes, Health Resource Use, and Cost in Patients with Early versus Late Dual or Triple Anti-Platelet Treatment for Acute Coronary Syndrome
Lomitapide: A Review of its Use in Adults with Homozygous Familial Hypercholesterolemia
62nd Annual Scientific Sessions of the American College of Cardiology: 9-11 March 2013; San Francisco, CA, USA